Increased frequency of a unique spleen tyrosine kinase bright memory b cell population in systemic lupus erythematosus

Arthritis and Rheumatology

Volumn 66, Issue 12, 2014, Pages 3424-3435

  Fleischer, Sarah J ^a,c   Giesecke, Claudia ^a,c   Mei, Henrik E ^a,c   Lipsky, Peter E ^b,d   Daridon, Capucine ^a   Dörner, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Charlottesville   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; PROTEIN KINASE SYK; TUMOR NECROSIS FACTOR ALPHA; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ADULT; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HEP 2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SECRETORY CELL; SJOEGREN SYNDROME; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; AGED; CASE CONTROL STUDY; ENZYMOLOGY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; PLASMA CELL; YOUNG ADULT;

ADULT; AGED; ANTIGENS, CD27; B-LYMPHOCYTE SUBSETS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHOSPHORYLATION; PLASMA CELLS; PROTEIN-TYROSINE KINASES; YOUNG ADULT;

EID: 84911995822     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38854     Document Type: Article

References (45)

1. Yuseff MI, Pierobon P, Reversat A, Lennon-Dumenil AM,. How B cells capture, process and present antigens: a crucial role for cell polarity. Nat Rev Immunol 2013; 13: 475-86.
2. Kulathu Y, Grothe G, Reth M,. Autoinhibition and adapter function of Syk. Immunol Rev 2009; 232: 286-99.
3. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 1995; 3: 549-60.
4. Hibbs ML, Harder KW, Armes J, Kountouri N, Quilici C, Casagranda F, et al. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med 2002; 196: 1593-604.
5. Kil LP, de Bruijn MJ, van Nimwegen M, Corneth OB, van Hamburg JP, Dingjan GM, et al. Btk levels set the threshold for B cell activation and negative selection of autoreactive B cells in mice. Blood 2012; 119: 3744-56.
6. Grammatikos AP, Ghosh D, Devlin A, Kyttaris VC, Tsokos GC,. Spleen tyrosine kinase (Syk) regulates systemic lupus erythematosus (SLE) T cell signaling. PloS One 2013; 8: e74550.
7. Dorner T, Jacobi AM, Lee J, Lipsky PE,. Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods 2011; 363: 187-97.
8. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE,. Identification and characterization of circulating human transitional B cells. Blood 2005; 105: 4390-8.
9. Lee J, Kuchen S, Fischer R, Chang S, Lipsky PE,. Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol 2009; 182: 4116-26.
10. Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000; 165: 5970-9.
11. high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann Rheum Dis 2010; 69: 305-8.
12. Culton DA, Nicholas MW, Bunch DO, Zhen QL, Kepler TB, Dooley MA, et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B cell tolerance loss. J Clin Immunol 2007; 27: 53-68.
13. Nicholas MW, Dooley MA, Hogan SL, Anolik J, Looney J, Sanz I, et al. A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol 2008; 126: 189-201.
14. low B cell population in the peripheral blood of patients with SLE. Clin Immunol 2004; 113: 161-71.
15. lo/neg B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 2002; 206: 502-13.
16. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188: 1679-89.
17. Jacobi AM, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum 2008; 58: 1762-73.
18. Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 2007; 178: 6624-33.
19. -) B cell population is increased in the peripheral blood of elderly people. Mech Ageing Dev 2009; 130: 681-90.
20. - (DN) B cells in aged humans. Ageing Res Rev 2011; 10: 274-84.
21. Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, Davis RS, et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med 2005; 202: 783-91.
22. - B cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection. PloS One 2009; 4: e5427.
23. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
24. Wirths S, Lanzavecchia A,. ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur J Immunol 2005; 35: 3433-41.
25. + plasmablasts is not abrogated by B cell depletion therapy with rituximab. Blood 2010; 116: 5181-90.
26. Frolich D, Giesecke C, Mei HE, Reiter K, Daridon C, Lipsky PE, et al. Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells. J Immunol 2010; 185: 3103-10.
27. Dorner T, Jacobi AM, Lipsky PE,. B cells in autoimmunity. Arthritis Res Ther 2009; 11: 247.
28. Odendahl M, Mei H, Hoyer BF, Jacobi AM, Hansen A, Muehlinghaus G, et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005; 105: 1614-21.
29. -/low B cells in Sjögren's syndrome-associated lymphoproliferation. Arthritis Rheum 2013; 65: 1085-96.
30. Doi H, Tanoue S, Kaplan DE,. Peripheral CD27-CD21- B cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol 2014; 150: 184-91.
31. hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010; 32: 129-40.
32. H gene somatic mutations in peripheral B cells from aged humans. Clin Exp Immunol 2003; 1331: 59-66.
33. Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, Miyasaka N,. Excessive production of IFN-γ in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J Immunol 2008; 181: 2211-9.
34. Aringer M, Smolen JS,. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 2004; 13: 344-7.
35. Mariette X,. How does BAFF activate B cells in patients with autoimmune diseases? Arthritis Res Ther 2012; 14: 106.
36. Pers JO, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005; 1050: 34-9.
37. Zorro S, Arias M, Riano F, Paris S, Ramirez LA, Uribe O, et al. Response to ODN-CpG by B cells from patients with systemic lupus erythematosus correlates with disease activity. Lupus 2009; 18: 718-26.
38. Wahren-Herlenius M, Dorner T,. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013; 382: 819-31.
39. Jacob N, Stohl W,. Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther 2011; 13: 228.
40. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610-5.
41. Eilertsen GO, Van Ghelue M, Strand H, Nossent JC,. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study. Rheumatology (Oxford) 2011; 50: 2197-205.
42. Giesecke C, Frolich D, Reiter K, Mei HE, Wirries I, Kuhly R, et al. Tissue distribution and dependence of responsiveness of human antigen-specific memory B cells. J Immunol 2014; 192: 3091-100.
43. Swaak AJ, Hintzen RQ, Huysen V, van den Brink HG, Smeenk JT,. Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course. Clin Rheumatol 1995; 14: 293-300.
44. + lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol 1992; 22: 993-9.
45. Kai K, Rikiishi H, Sugawara S, Takahashi M, Takada H, Kumagai K,. Lipopolysaccharide-dependent down-regulation of CD27 expression on T cells activated with superantigen. Immunology 1999; 98: 289-95.